-
Addressing the Unique Mental Health Challenges Brought on by Aging
Older adults are one of the fastest-growing demographics in the nation and in New York State. There are currently about 4.6 million New Yorkers who are 60 years of age or older and another 4.2 million between the ages of 45 and 59. Individuals with wisdom and life experience are a gift to...
-
Federal Study Examines Care Following Nonfatal Overdose Among Medicare Beneficiaries; Identifies Effective Interventions and Gaps in Care
Researchers from the Substance Abuse and Mental Health Services Administration (SAMHSA), the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA), Centers for Medicare & Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC) found that among...
-
Can Medical Cannabis Treat Chronic Pain?
An estimated 20% of adults in the United States experience chronic pain (Zelaya, 2020). For many years, opioid analgesics were the primary medications prescribed for chronic pain, but the significant increase in opioid prescriptions at high doses and for long durations has been associated with...
-
Only 1 in 5 U.S. Adults With Opioid Use Disorder Received Medications to Treat It in 2021
In 2021, an estimated 2.5 million people aged 18 years or older in the U.S. had opioid use disorder in the past year, yet only 1 in 5 of them (22%) received medications to treat it, according to a new study. Some groups were substantially less likely to receive medication, including Black adults,...
-
Marijuana and Hallucinogen Use, Binge Drinking Reached Historic Highs Among Adults 35 to 50
Past-year use of marijuana and hallucinogen use by adults 35 to 50 years old continued a long-term upward trajectory to reach all-time highs in 2022, according to the Monitoring the Future (MTF) panel study, an annual survey of substance use behaviors and attitudes of adults 19 to 60 years old....
-
Higher Buprenorphine Doses Associated With Improved Retention in Treatment for Opioid Use Disorder
Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a study of patients prescribed buprenorphine in Rhode Island from 2016 to 2020, as fentanyl became widely available. The...
-
Reported Drug Use Among Adolescents Continued to Hold Below Pre-Pandemic Levels in 2023
The percentage of adolescents reporting they used any illicit substances in 2023 continued to hold steady below the pre-pandemic levels reported in 2020, with 10.9% of eighth graders, 19.8% of 10th graders, and 31.2% of 12th graders reporting any illicit drug use in the past year, according...
-
Men Died of Overdose at 2-3 Times Greater a Rate Than Women in the U.S. In 2020-2021
Men were significantly more vulnerable than women to overdose deaths involving opioid and stimulant drugs in 2020-2021, according to a new study analyzing death records data from across the United States. The study found that men had a 2–3 times greater rate of overdose mortality from opioids...
-
Only 1 in 4 Adolescent Treatment Facilities Offer Buprenorphine for Opioid Use Disorder
Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study. Only 1 in 8 offer buprenorphine for ongoing treatment. These findings highlight a significant gap in...
-
Still Reaching: The Syndemics that Complicate and Characterize How Drugs and HIV Intersect in People’s Lives
Nearly 42 years ago, the Centers for Disease Control and Prevention (CDC) reported a rare pneumonia in five gay men, marking the recognized start of the HIV/AIDS epidemic. While we often hear about those men’s sexuality, we hear less often about their substamce use. As the 1981 report notes,...
